Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) is intrinsically linked to gut dysbiosis, yet the precise mechanisms by which specific bacterial species contribute to tumor-associated phenotypes remain incompletely understood. Fecal microbiome analysis of CRC patients revealed enrichment of Bacteroides fragilis , Fusobacterium animalis , Parvimonas micra , Peptostreptococcus anaerobius and Peptostreptococcus stomatis compared with healthy controls. Using in vitro models, we found that exposure to these candidate bacteria, particularly F. animalis and B. fragilis , enhanced CRC cell proliferation and induced a pro-inflammatory response characterized by increased IL-8 and CXCL1 secretion. Bacterial exposure also compromised epithelial barrier integrity, as evidenced by increased permeability and reduced expression of the tight junction protein occludin. These changes were accompanied by increased expression of the epithelial-to-mesenchymal transition (EMT)-associated transcription factors SNAI1 and SNAI2 , together with increased migratory capacity. Furthermore, pharmacological inhibition of the urokinase-type plasminogen activator (PLAU) attenuated bacteria-induced CCL5 expression in SW480 cells, suggesting that PLAU-associated signaling may contribute to this inflammatory response under the conditions tested. Overall, these findings suggest that CRC-associated anaerobic bacteria can promote tumor-associated cellular phenotypes through effects on epithelial barrier integrity, inflammatory signaling and EMT-associated processes.
No takes yet. Share an insight, caveat, or question.
Nión et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: